Zobrazeno 1 - 10
of 199
pro vyhledávání: '"Matthew T Bennett"'
Autor:
Matthew T. Bennett, MD
Publikováno v:
Heart Rhythm O2, Vol 5, Iss 11, Pp 762-763 (2024)
Externí odkaz:
https://doaj.org/article/b8d20d91d3ed4af08c37528c3fc979ce
Autor:
Shanjot Brar, Mehima Kang, Amit Sodhi, Marc W. Deyell, Zachary Laksman, Jason G. Andrade, Matthew T. Bennett, Andrew D. Krahn, John Yeung-Lai-Wah, Richard G. Bennett, Amanda Barlow, Jasmine Grewal, Gnalini Sathananthan, Santabhanu Chakrabarti
Publikováno v:
International Journal of Cardiology Congenital Heart Disease, Vol 16, Iss , Pp 100508- (2024)
Background: Surgically repaired Tetralogy of Fallot (rTOF) is associated with progressive right ventricular hypertrophy (RVH) and dilation (RVD). Accurate estimation of RVH/RVD is vital for the ongoing management of this patient population. The utili
Externí odkaz:
https://doaj.org/article/b4168f81ee7b41fb9b4c2cfa3213be87
Autor:
James E. Ip, Benoit Coutu, Matthew T. Bennett, A. Shekhar Pandey, Bruce S. Stambler, Philip Sager, Michael Chen, Silvia Shardonofsky, Francis Plat, A. John Camm
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 19 (2023)
Background Self‐administration of investigational intranasal L‐type calcium channel blocker etripamil during paroxysmal supraventricular tachycardia (PSVT) appeared safe and well‐tolerated in the phase 3 NODE‐301 (Multi‐Centre, Randomized,
Externí odkaz:
https://doaj.org/article/65dc302027e8435e862265292c95fd1d
Autor:
Erika A. Petersen, MD, Thomas G. Stauss, MD, James A. Scowcroft, MD, Elizabeth S. Brooks, PhD, Judith L. White, MD, Shawn M. Sills, MD, Kasra Amirdelfan, MD, Maged N. Guirguis, MD, Jijun Xu, MD, PhD, Cong Yu, MD, Ali Nairizi, MD, Denis G. Patterson, DO, Kostandinos C. Tsoulfas, MD, Michael J. Creamer, DO, Vincent Galan, MD, Richard H. Bundschu, MD, Neel D. Mehta, MD, Dawood Sayed, MD, Shivanand P. Lad, MD, PhD, David J. DiBenedetto, MD, Khalid A. Sethi, MD, Johnathan H. Goree, MD, Matthew T. Bennett, MD, Nathan J. Harrison, MD, Atef F. Israel, MD, Paul Chang, MD, Paul W. Wu, MD, Charles E. Argoff, MD, Christian E. Nasr, MD, Rod S. Taylor, PhD, David L. Caraway, MD, PhD, Nagy A. Mekhail, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 4, Pp 347-360 (2022)
Objective: To evaluate high-frequency (10-kHz) spinal cord stimulation (SCS) treatment in refractory painful diabetic neuropathy. Patients and Methods: A prospective, multicenter randomized controlled trial was conducted between Aug 28, 2017 and Marc
Externí odkaz:
https://doaj.org/article/7daa218aa0734b449a9c83190d92165e
Autor:
Sina Safabakhsh, BSc, Darson Du, MD, Janet Liew, BSc, Jeremy Parker, PhD, Cheryl McIlroy, BSN, Elina Khasanova, MD, Praveen Indraratna, MD, Philipp Blanke, MD, Jonathon Leipsic, MD, Jason G. Andrade, MD, Matthew T. Bennett, MD, Nathaniel M. Hawkins, MBChB, MD, Shantabanu Chakrabarti, MD, John Yeung, MD, Marc W. Deyell, MD, Andrew D. Krahn, MD, FHRS, Robert Moss, MD, Kevin Ong, MD, Zachary Laksman, MD, MSc
Publikováno v:
CJC Open, Vol 4, Iss 3, Pp 305-314 (2022)
Background: Sudden cardiac death (SCD) risk stratification in hypertrophic cardiomyopathy (HCM) currently relies on arrhythmic burden quantification by 24 or 48-hour Holter monitoring. Whether this approach adequately captures arrhythmic burden, comp
Externí odkaz:
https://doaj.org/article/c1170a9da7514c05b8db6278b2e4971f
Autor:
Samaneh Salimian, PhD, Marc W. Deyell, MD, MSc, FHRS, Jason G. Andrade, MD, FHRS, Santabhanu Chakrabarti, MBChB, Matthew T. Bennett, MD, FHRS, Andrew D. Krahn, MD, FHRS, Nathaniel M. Hawkins, MBChB, MD, MPH
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 6, Pp 698-709 (2021)
Background: Heart failure and reduced ejection fraction (HFrEF) is the predominant indication for cardiac resynchronization therapy (CRT) and implantable cardioverter-defibrillator (ICD) implantation. The care gap and opportunity to optimize guidelin
Externí odkaz:
https://doaj.org/article/b1ae47925fa342d9ae4213cec9a57b94
Autor:
Nelson Lu, MD, Jenny MacGillivray, BScPharm, Jason G. Andrade, MD, FHRS, Andrew D. Krahn, MD, FHRS, Nathaniel M. Hawkins, MD, Zachary Laksman, MD, Marc W. Deyell, MD, MSc, FHRS, Shanta Chakrabarti, MD, FHRS, John A. Yeung-Lai-Wah, MD, Matthew T. Bennett, MD, FHRS
Publikováno v:
Heart Rhythm O2, Vol 2, Iss 1, Pp 46-52 (2021)
Background: Rate control medications are foundational in the management of persistent atrial fibrillation (AF). There are no guidelines for adjusting these medications prior to elective direct-current cardioversion (DCCV). Objective: To derive and va
Externí odkaz:
https://doaj.org/article/6f8ef55081704c42b4c68b2662c121a8
Autor:
Samaneh Salimian, Marc W. Deyell, Matthew T. Bennett, Zachary Laksman, Santabhanu Chakrabarti, Andrew D. Krahn, Jason G. Andrade, Nathaniel M. Hawkins
Publikováno v:
Heart Rhythm O2. 4:336-340
Autor:
Samaneh Salimian, Nima Moghaddam, Marc W. Deyell, Sean A. Virani, Matthew T. Bennett, Andrew D. Krahn, Jason G. Andrade, Nathaniel M. Hawkins
Publikováno v:
Clinical Research in Cardiology. 112:158-166
Autor:
Brianna Davies, Jacqueline Forman, Cheryl McIlroy, Heather Joe, Sina Safabakhsh, Janet Liew, Jeremy Parker, Darson Du, Jason G Andrade, Matthew T Bennett, Nathaniel M Hawkins, Santabhanu Chakrabarti, John Yeung, Marc W Deyell, Andrew D Krahn, Robert Moss, Kevin Ong, Zachary Laksman
Publikováno v:
European Journal of Cardiovascular Nursing.
Aims Hypertrophic cardiomyopathy (HCM) is the most common inherited heart disease. Insertable cardiac monitors (ICMs) are increasingly used in this population to provide closer monitoring, with the potential for notification systems. However, little